Cost Is One of the Biggest Barriers to Myfembree Adherence — Here's How Providers Can Help

Myfembree (Relugolix/Estradiol/Norethindrone Acetate) is a clinically effective once-daily oral treatment for heavy menstrual bleeding associated with uterine fibroids and moderate to severe endometriosis pain. But at $1,200 to $1,700 per month for the brand-name product, cost is a significant barrier to treatment initiation and adherence.

As a prescriber, you're in a unique position to help patients navigate the financial landscape of this medication. This guide outlines the savings programs, discount options, and clinical strategies available to reduce out-of-pocket costs for your patients on Myfembree.

What Patients Are Actually Paying

Understanding the current pricing landscape helps frame cost conversations with patients:

• Brand-name Myfembree (cash price): $1,200 – $1,700 per 28-day supply
• Generic Relugolix/Estradiol/Norethindrone Acetate (with discount coupon): Approximately $1,150 per 28-day supply
• With commercial insurance: Varies widely. Many plans cover Myfembree but require prior authorization and may impose step therapy requirements. Copays can range from $0 (with manufacturer assistance) to several hundred dollars per month.
• Medicare Part D: Typically covered with tiered copays. The 2025 Part D out-of-pocket cap of $2,000 per year provides a ceiling on annual costs, which is particularly relevant for a medication at this price point.

The reality is that without financial assistance, many patients cannot afford sustained treatment. Studies consistently show that medication cost is one of the top reasons patients discontinue therapy or never fill their initial prescription.

Manufacturer Savings Programs

Myfembree Copay Assistance Program

The manufacturer copay program is often the most impactful resource for commercially insured patients:

• Eligibility: Patients with commercial (private) insurance
• Benefit: Eligible patients may pay as little as $0 per fill
• Enrollment: Through the TrialCard portal at portal.trialcard.com/myovant/myfembree/copay
• Exclusions: Not available for patients covered by government insurance programs (Medicare, Medicaid, Tricare, VA)

Clinical workflow tip: Have your staff enroll eligible patients at the point of prescribing. The copay card can often be activated before the patient arrives at the pharmacy, eliminating a common source of sticker shock and prescription abandonment.

Myovant Sciences Patient Assistance Program (PAP)

For patients who are uninsured or underinsured:

• Myovant Sciences offers a patient assistance program that may provide Myfembree at no cost to qualifying patients
• Eligibility is typically based on income and insurance status
• Patients can also be referred to NeedyMeds (needymeds.org) and RxAssist (rxassist.org) for additional PAP resources

Clinical workflow tip: Keep PAP applications in your office or provide the URL to your staff. For uninsured patients, initiating the PAP application before sending the prescription can prevent delays and frustration.

Coupon and Discount Cards

For patients paying out-of-pocket or with high-deductible plans, discount cards can provide meaningful savings — especially on the generic formulation:

• SingleCare: Offers coupons for generic Relugolix/Estradiol/Norethindrone Acetate at approximately $1,150/month
• GoodRx: Price comparison and coupons available at participating pharmacies
• RxSaver, Optum Perks, BuzzRx: Additional discount card options that may offer competitive pricing

While the savings over brand cash price may seem modest for this particular medication, discount cards are especially valuable for:

• Patients in insurance deductible periods
• Patients whose plans don't cover Myfembree
• Patients transitioning between insurance plans

Important note for providers: Manufacturer copay cards and third-party discount cards generally cannot be combined. Help patients determine which option offers the greatest savings in their specific situation.

Generic Alternatives and Therapeutic Substitution

Generic Myfembree

A generic version of Myfembree (Relugolix/Estradiol/Norethindrone Acetate) is now available. While the generic price is still substantial (approximately $1,150/month with coupons), it may offer savings for some patients depending on their insurance formulary and pharmacy.

When prescribing, consider writing for the generic when possible, or ensuring your prescription allows generic substitution unless there's a clinical reason to require the brand.

Therapeutic Alternatives

If cost remains prohibitive despite financial assistance programs, consider discussing therapeutic alternatives with your patients:

• Oriahnn (Elagolix/Estradiol/Norethindrone Acetate) — Similar mechanism with hormonal add-back, but requires twice-daily dosing. FDA-approved only for uterine fibroids. Pricing is comparable, but formulary coverage may differ.
• Orilissa (Elagolix) — GnRH antagonist without add-back therapy. Approved for endometriosis. May be less expensive for some patients but carries greater bone loss risk.
• Lupron Depot (Leuprolide Acetate) — Injectable GnRH agonist. Older therapy with established pricing. May be covered differently under medical benefit (injectable) vs. pharmacy benefit (oral).
• Hormonal IUD (Mirena) — For fibroids, a Levonorgestrel IUD can reduce heavy bleeding. Significantly lower ongoing cost. Covered as a preventive service under most insurance plans.
• Oral contraceptives or progestins — First-line options for both conditions that are substantially less expensive, though less effective for moderate-to-severe symptoms.

For a patient-facing comparison, you can direct patients to our article on alternatives to Myfembree.

Building Cost Conversations Into Your Workflow

Proactively addressing cost can improve adherence, reduce prescription abandonment, and strengthen the patient-provider relationship. Here are practical strategies:

1. Ask About Cost Concerns at the Point of Prescribing

Many patients won't volunteer that they can't afford a medication. A simple question like "Would it be helpful if we looked into savings programs for this medication?" can open the door. Normalize the conversation — Myfembree is an expensive drug, and most patients will benefit from some form of financial assistance.

2. Build Financial Navigation Into Your Prescribing Workflow

Designate a staff member (nurse, medical assistant, or financial counselor) to:

• Check insurance formulary coverage and prior authorization requirements before prescribing
• Enroll eligible patients in the manufacturer copay program at the point of prescribing
• Initiate PAP applications for uninsured patients
• Provide patients with a printed list of discount card options

3. Use Specialty Pharmacies When Appropriate

Specialty pharmacies often have dedicated teams to help with prior authorizations, copay programs, and ongoing refill management. For a medication like Myfembree, routing prescriptions through a specialty pharmacy can reduce administrative burden on your practice while improving the patient experience.

4. Monitor for Non-Adherence Related to Cost

If a patient reports skipping doses, taking the medication every other day, or not filling refills on time, explore whether cost is a factor. These behaviors are common with expensive medications and can be addressed with the resources outlined above.

5. Direct Patients and Colleagues to Medfinder

For providers looking to streamline the process of helping patients find and afford their medications, Medfinder for Providers offers tools to check pharmacy availability and connect patients with resources. Patients can also use Medfinder directly to find pharmacies with Myfembree in stock.

Final Thoughts

Myfembree is a valuable treatment option for uterine fibroids and endometriosis, but its cost can be a significant barrier to treatment success. By proactively connecting patients with copay assistance, patient assistance programs, and discount resources — and by building cost conversations into your clinical workflow — you can help ensure that cost doesn't stand between your patients and effective treatment.

For more provider-focused resources on Myfembree, see our guides on what providers need to know about Myfembree availability and how to help patients find Myfembree in stock.